Invention

NgAgo

Biomedical Engineering

NgAgo is a single-stranded DNA-guided Argonaute endonuclease derived from the bacterium Natronobacterium gregoryi, proposed in May 2016 by Chunyu Han and colleagues and published in Nature Biotechnology as a genome-editing tool. Its developers claimed it could edit genes with high accuracy and efficiency without requiring the protospacer adjacent motif that CRISPR/Cas9 systems need, which would have made it a notable alternative editing technology. Multiple other research groups were unable to reproduce the results, and the original authors retracted the study in August 2017; a 2018 university investigation found the team had not intentionally deceived the scientific community even though their findings were flawed, and a 2019 preprint suggested the earlier failures might have stemmed from difficulties purifying the protein rather than a fundamental flaw in the underlying concept, leaving NgAgo's real capability unresolved.

Connections

In Field

Source NgAgo (Wikipedia)
Sources
NgAgo (Wikipedia)
  • In Field: Biomedical Engineering, Lead paragraph
    NgAgo is a single-stranded DNA (ssDNA)-guided Argonaute endonuclease, an acronym for Natronobacterium gregoryi Argonaute.
  • In Group: Tissue and Genome Engineering Technologies, Lead paragraph
    NgAgo is a single-stranded DNA (ssDNA)-guided Argonaute endonuclease, an acronym for Natronobacterium gregoryi Argonaute.
View the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.

Technology and Engineering Atlas

How Things Are Built
Sign In
Text size
100%
Theme